1. EachPod

GI Insights - Podcast

GI Insights

Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.

Science & Medicine Health Medicine
Update frequency
every 6 days
Episodes
623
Years Active
2008 - 2025
Share to:
Barrett's Esophagus and Esophageal Cancer

Barrett's Esophagus and Esophageal Cancer

Host: Mark DeLegge, MD
Guest: Donald Castell, MD

How common is Barrett's esophagus in patients with chronic gastroesophageal reflux disease (GERD) or asymptomatic reflux? What risk fact…

Wed 17 Dec 2008
Understanding and Treating Chronic Constipation

Understanding and Treating Chronic Constipation

Host: Mark DeLegge, MD
Guest: David Peura, MD

Constipation is a common symptom that presents more often in women and as patients get older. What are the primary and secondary causes of …

Tue 16 Dec 2008
Drug-Induced Liver Injury

Drug-Induced Liver Injury

Host: Mark DeLegge, MD
Guest: Rowen Zetterman, MD

Acetaminophen, vitamin supplements and antibiotics are just a few of the medications that can cause liver injury. What are the signs of…

Tue 16 Dec 2008
The Plight of the Investigator

The Plight of the Investigator

Host: Mark DeLegge, MD
Guest: Mark Donowitz, MD

Are there fewer physician-scientists today than there were a few decades ago? What does the future landscape look like for medical resear…

Tue 16 Dec 2008
Barrett's Esophagus and Esophageal Cancer

Barrett's Esophagus and Esophageal Cancer

Host: Mark DeLegge, MD
Guest: Donald Castell, MD

How common is Barrett's esophagus in patients with chronic gastroesophageal reflux disease (GERD) or asymptomatic reflux? What risk fact…

Tue 16 Dec 2008
Outcomes Research: What Every Physician Should Know

Outcomes Research: What Every Physician Should Know

Host: Jay Goldstein, MD
Guest: Glenn Eisen, MD, MPH

What does outcomes research measure, and how does it differ from clinical trials? Is evidence-based medicine related to outcomes rese…

Wed 03 Dec 2008
New Treatments to Reduce Liver Damage From Hepatitis B

New Treatments to Reduce Liver Damage From Hepatitis B

Host: Jay Goldstein, MD
Guest: Scott Cotler, MD

Untreated hepatitis B can lead to cirrhosis and liver cancer. What methods are available for physicians to treat hepatitis B patients? Ho…

Wed 03 Dec 2008
Outcomes Research: What Every Physician Should Know

Outcomes Research: What Every Physician Should Know

Host: Jay Goldstein, MD
Guest: Glenn Eisen, MD, MPH

What does outcomes research measure, and how does it differ from clinical trials? Is evidence-based medicine related to outcomes rese…

Wed 03 Dec 2008
New Treatments to Reduce Liver Damage From Hepatitis B

New Treatments to Reduce Liver Damage From Hepatitis B

Host: Jay Goldstein, MD
Guest: Scott Cotler, MD

Untreated hepatitis B can lead to cirrhosis and liver cancer. What methods are available for physicians to treat hepatitis B patients? Ho…

Wed 03 Dec 2008
Shifts in Crohn's Disease Treatment Models

Shifts in Crohn's Disease Treatment Models

Host: Mark DeLegge, MD
Guest: William J. Sandborn, MD

The current treatment paradigm for Crohn's disease is a pyramid approach, where patients are given the safest medications before pu…

Wed 19 Nov 2008
Managing Esophageal Cancer From the Onset

Managing Esophageal Cancer From the Onset

Host: Mark DeLegge, MD
Guest: Prateek Sharma, MD

Esophageal cancer survival rates greatly decline when the cancer has reached its late stages, so detecting neoplasia in a Barrett's esop…

Wed 19 Nov 2008
Shifts in Crohn's Disease Treatment Models

Shifts in Crohn's Disease Treatment Models

Host: Mark DeLegge, MD
Guest: William J. Sandborn, MD

The current treatment paradigm for Crohn's disease is a pyramid approach, where patients are given the safest medications before pu…

Tue 18 Nov 2008
Managing Esophageal Cancer From the Onset

Managing Esophageal Cancer From the Onset

Host: Mark DeLegge, MD
Guest: Prateek Sharma, MD

Esophageal cancer survival rates greatly decline when the cancer has reached its late stages, so detecting neoplasia in a Barrett's esop…

Tue 18 Nov 2008
Measuring Health-Related Quality of Life

Measuring Health-Related Quality of Life

Host: Jay Goldstein, MD
Guest: Brennan Spiegel, MD, MSHS

In its 1948 charter constitution, the World Health Organization defined health as "a state of complete physical, mental and soci…

Tue 11 Nov 2008
Post-Election Update: Physician Medicare Reimbursement

Post-Election Update: Physician Medicare Reimbursement

Host: Jay Goldstein, MD
Guest: Carla Ginsburg, MD, MPH

Physicians continue to face payment cuts from Medicare, largely due to a flawed payment formula. What is on the horizon for 2009 a…

Tue 11 Nov 2008
Helicobacter Pylori: Still a Problem in the U.S?

Helicobacter Pylori: Still a Problem in the U.S?

Host: Jay Goldstein, MD
Guest: David Peura, MD

Helicobacter pylori, often known as H. pylori, was discovered in the 1980s and is found worldwide in the stomachs of billions of people. H…

Tue 11 Nov 2008
Measuring Health-Related Quality of Life

Measuring Health-Related Quality of Life

Host: Jay Goldstein, MD
Guest: Brennan Spiegel, MD, MSHS

In its 1948 charter constitution, the World Health Organization defined health as "a state of complete physical, mental and soci…

Tue 11 Nov 2008
Post-Election Update: Physician Medicare Reimbursement

Post-Election Update: Physician Medicare Reimbursement

Host: Jay Goldstein, MD
Guest: Carla Ginsburg, MD, MPH

Physicians continue to face payment cuts from Medicare, largely due to a flawed payment formula. What is on the horizon for 2009 a…

Tue 11 Nov 2008
Helicobacter Pylori: Still a Problem in the U.S?

Helicobacter Pylori: Still a Problem in the U.S?

Host: Jay Goldstein, MD
Guest: David Peura, MD

Helicobacter pylori, often known as H. pylori, was discovered in the 1980s and is found worldwide in the stomachs of billions of people. H…

Tue 11 Nov 2008
Evolving Treatment of Inflammatory Bowel Disease

Evolving Treatment of Inflammatory Bowel Disease

Host: Jay Goldstein, MD
Guest: Richard Fedorak, MD

Steroids used to be the standard treatment for inflammatory bowel disease. But now biologic and immunosuppresive therapies are often u…

Tue 04 Nov 2008
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.